A novel and efficient synthesis of 3-aryl-5-(2-hydroxybenzoyl)pyridin-2(1H)-ones by re-cyclization of N-(oxopyranochromenyl)acetamides and their antineoplastic screening
- 32 Downloads
We have developed a novel, simple and efficient methodology for preparation of yet unknown 3-aryl-5-(2-hydroxybenzoyl)pyridin-2(1H)-ones 3(a–g) by EtONa driven re-cyclization of N-(3-aryl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl)acetamides 2(a–g) in good yields (80–95%). A mechanism for this reaction was proposed. The 3-aryl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetates 1(a–g) were prepared by cyclocondensation from 3-formylchromones (4-oxo-4H-chromene-3-carbaldehydes) and acetic acids in 64–86% yields. Acetamides 2(a–g) were obtained by reaction of 3-aryl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetates 1(a–g) with AcNH2 catalyzed by pTsOH in 80–93% yields. Click chemistry precursors 4(a,d) and 5(a,d) were prepared by propargylation of 3(a,d) in 92–98% yields. They can serve for construction of more complex molecules possessing pyridone skeleton of 3. Eleventh novel compounds 3(a–g), 4(a,d) and 5(a,d) were screened on their anticancer activity on a panel of human tumour cell lines by NCI USA. We found that pyridones 3–5 selectively inhibit the growth of some of the tumour cell lines at 10−5 M (up to -33% compared to a control). The most sensitive tumour cell lines originated from kidney, breast, skin, ovary, blood and lung.
Keywords3-aryl-5-(2-hydroxybenzoyl)pyridin-2(1H)-ones N-(3-aryl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl)acetamides re-cyclization mechanism NCI tumour cell lines Click chemistry precursors
This research was supported by the Biomagi, Ltd., NCI USA, VEGA 1/0670/18, Comenius University Science Park funded by the ERDF Grant no. ITMS 26240220086 (HPLC MS).
Matúš Čakurda importantly contributed to carrying out experiments and writing of this paper.
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- Bari A, Parvez MK, Khan AA, Alanazi AM, Syed SA, Al-Dosari MS, Alobaid AM (2016) A facile one-pot synthesis and anticancer evaluation of novel substituted 1,2-dihydropyridine and 1,2,3,4-tetrahydropyrimidine analogues. J Heterocycl Chem 53:377–382. https://doi.org/10.1002/jhet.2400 CrossRefGoogle Scholar
- Chand K, Alsoghier HM, Chaves S, Santos MA (2016) Tacrine-(hydroxybenzoyl-pyridone) hybrids as potential multifunctional anti-Alzheimer’s agents: aChE inhibition, antioxidant activity and metal chelating capacity. J Inorg Biochem 163:266–277. https://doi.org/10.1016/j.jinorgbio.2016.05.005 CrossRefGoogle Scholar
- Lácova M, Loos D, Chovancová J, Králová K (1999, 2000) Phthalides and chromones from 4-coumarin acetic acids. Study of beneficial effects of microwave irradiation on synthesis. Electronic conference proceedings of ECSOC-3 and ECSOC-4, Sept. 1–30, 1999 and 2000:181–193. http://www.mdpi.org/ecsoc/ecsoc-3/a0039/a0039.htm (accessed 20nd April 2018)
- Mehrparvar S, Balalaie S, Rabbanizadeh M, Ghabraie E, Rominger F (2014) An efficient tandem approach for the synthesis of functionalized 2-pyridone-3-carboxylic acids using three-component reaction in aqueous media. Mol Divers 18:535–543. https://doi.org/10.1007/s11030-014-9522-x CrossRefGoogle Scholar
- NCI search for all data by compound identifiers (2018) https://dtp.cancer.gov/dtpstandard/dwindex/index.jsp (accessed 28th April 2018)
- NCI-60 human tumour cell lines screen (2018) https://dtp.cancer.gov/discovery_development/nci-60/default.htm (accessed 28th April 2018)
- Rajkumar K, Suman P, Raju BCh (2015) Facile construction of novel heterocyclic compounds: three-component, one-pot synthesis of 2-hydroxybenzoyl-1,2-dihydropyridine-3-carboxylates, ketones, pyridone-3-carboxylates and benzopyrido-1,3-oxazole-4-carboxylates. RSC Adv 5:73850–73858. https://doi.org/10.1039/c5ra10185a CrossRefGoogle Scholar
- Sarma AK, Yadav P, Chand K, Sharma SK (2016) Design and synthesis of novel 2′-hydroxy group substituted 2-pyridone derivatives as anticancer agents. Indian. J. Chem Sec B 55B:492–500Google Scholar
- SciFinder database https://scifinder.cas.org/scifinder/ (accessed 22nd April 2018)
- NCI data search (2018) https://dtp.cancer.gov/dtpstandard/dwindex/index.jsp (accessed 28th April 2018)
- The Compare Analysis https://dtp.cancer.gov/databases_tools/compare.htm (accessed 28th April 2018)